Tranexamic acid, a medi- cation to help clotting in trauma patients |
28 Mar 2014
Fellowship to study medication for helping blood clotting in trauma patients
Discovering the genetic origin of craniofacial defects
Dr Seb Dworkin on his scientific ‘fishing
expedition’ with zebrafish embryos,
teasing out the genetic origin of cranio- facial defects |
The alternative is to prevent the defect from occurring in the first place, which means its cause must be understood. The problem stems from an error in the genetic instructions for the facial formation. However, which genes? Which sequences? What affects the genes? There are hundreds of possible causes, and without knowing exactly which genes are involved in the process of embryo formation, it will not be possible to develop preventive gene therapies.
Your active contribution to medical research is highly valued! Invitation to participate in CCS research studies
Image: Debbra Sweet |
27 Mar 2014
Participants sought: Investigating Ondansetron for chronic residual schizophrenia
The purpose of this study is to investigate the
use of the medication Ondansetron as an adjunctive or add-on therapy to
existing anti-psychotic medication in the treatment of schizophrenia
symptoms. Ondansetron is a well established medication which is approved
in Australia for the treatment of drug-induced nausea and vomiting.
However, various case studies and clinical studies have shown
Ondansetron to also be effective in the treatment of symptoms associated
with persistent schizophrenia.
Participants sought: An adjunctive pro-cognitive treatment in schizophrenia
Website link: http://www.maprc.org.au/psychopharmacology
Ethics Committee Project Number: 110/13
Participants sought: Are you interested in trying a new non-medication treatment for Depression?
The Monash Alfred Psychiatry Research Centre (MAPrc) is seeking volunteers who are currently experiencing depression
to help us investigate a new antidepressant treatment. This study is looking at whether cognitive control training can help
alleviate the symptoms of depression. It is also investigating whether a
mild form of brain stimulation called transcranial electrical
stimulation can be used to boost the impact of cognitive control
training. Transcranial electrical stimulation is a safe, mild and
non-invasive means of stimulating nerves cells in the brain.
Participants sought: Do you have Type 2 diabetes and sit for large portions of the day?
Who can take part in this study conducted by the Baker IDI
Participants sought: The role of wheat gluten in causing gastrointestinal symptoms and changes to mental health
Volunteers are required to investigate the role of wheat gluten in
causing gastrointestinal symptoms and changes in mental health in people
who do not have coeliac disease.
We are looking for participants who:
We are looking for participants who:
- Have found that following a gluten-free diet has relieved their gut symptoms
- Have found that following a gluten free diet makes them feel better
- Have had coeliac disease ruled out
- Have currently well-controlled symptoms
- Are adherent to a strict gluten-free diet
Subscribe to:
Posts (Atom)